Camp4 Therapeutics (CAMP) Other Accumulated Expenses (2023 - 2025)
Camp4 Therapeutics (CAMP) reported Other Accumulated Expenses of $27000.0 for Q4 2025, down 84.66% on a YoY basis from $176000.0 in Q4 2024, and down 84.66% sequentially from $176000.0 in Q4 2024.
Camp4 Therapeutics (CAMP) Other Accumulated Expenses (2023 - 2025) Analysis & Trends
Camp4 Therapeutics (CAMP) has 3 years of Other Accumulated Expenses data on file, last reported at $27000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Accumulated Expenses fell 84.66% year-over-year to $27000.0; the trailing twelve-month figure through Dec 2025 stood at $27000.0 (down 84.66% YoY), and the FY2025 full-year result was $27000.0, down 84.66% from the prior year.
- Other Accumulated Expenses fell to $27000.0 in Q4 2025, from $176000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $369000.0 in Q3 2024 to a low of $27000.0 in Q4 2025.
- A 3-year average of $215250.0 and a median of $232500.0 in 2023 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses slumped 39.1% in 2024 and tumbled 84.66% in 2025, its largest moves.
- Tracing CAMP's Other Accumulated Expenses over 3 years: stood at $289000.0 in 2023, then tumbled by 39.1% to $176000.0 in 2024, then plunged by 84.66% to $27000.0 in 2025.
- Business Quant data shows CAMP's Other Accumulated Expenses at $27000.0 in Q4 2025, $176000.0 in Q4 2024, and $369000.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Camp4 Therapeutics | 183.62 Mn | 183.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 176,000.00 |
| Sep 30, 2024 | 369,000.00 |
| Dec 31, 2023 | 289,000.00 |